Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Household Study of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus Community Burden, Transmission Dynamics and Viral Interaction in South Africa (the PHIRST-C Study)

NCT05277298 is registered in ClinicalTrials.gov with National Institute for Communicable Diseases, South Africa as lead sponsor.

NCT NCT05277298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05277298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Household Study of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus Community Burden, Transmission Dynamics and Viral Interaction in South Africa (the PHIRST-C Study)
Lead sponsor
National Institute for Communicable Diseases, South Africa
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2020
Completion date
December 31, 2022
Enrollment
1,200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, respiratory syncytial virus (rsv), sars-cov-2 infection